JEMPERLI dostarlimab 500 mg solution for infusion 10 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

jemperli dostarlimab 500 mg solution for infusion 10 ml vial

glaxosmithkline australia pty ltd - dostarlimab, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: sodium citrate dihydrate; arginine hydrochloride; sodium chloride; polysorbate 80; water for injections; citric acid monohydrate - jemperli is indicated in combination with carboplatin and paclitaxel for the treatment of adult patients with primary advanced or recurrent mismatch repair deficient (dmmr)/microsatellite instability-high (msi-h) endometrial cancer.,jemperli is indicated as monotherapy for the treatment of adult patients with recurrent or advanced mismatch repair deficient (dmmr) endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

D50 Infusion Kenya - English - Pharmacy and Poisons Board

d50 infusion

glucose intravenous infusion - infusion - glucose intravenous 50%w/v - glucose

GLUCOSE INTRAVENOUS INFUSION BP 5 %w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose intravenous infusion bp 5 %w/v solution for infusion

b. braun medical limited - glucose - solution for infusion - 5 %w/v - plasma substitutes and perfusion solutions b05ba03 solutions for parenteral nutrition v07ab solvents and diluting agents, incl. irrigating solutions

Glucose Intravenous Infusion BP 5% w/v solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose intravenous infusion bp 5% w/v solution for infusion

b. braun melsungen ag - glucose - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.45% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6024) Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.45% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6024)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.9% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6066) Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.9% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6066)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 9 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

DBL Aciclovir 500mg/20mL Intravenous infusion injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dbl aciclovir 500mg/20ml intravenous infusion injection vial

pfizer australia pty ltd - aciclovir, quantity: 25 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - aciclovir intravenous infusion is indicated for the purpose of 1. promoting resolution of acute clinical manifestations of mucocutaneous herpes simplex virus infections in immunocompromised patients. 2. treatment of severe first episode primary or non- primary genital herpes in immune competent patients. 3. treatment of acute manifestations of varicella zoster virus infection in immunocompromised patients. 4. treatment of shingles (varicella zoster virus infection) in immune competent patients who show very severe acute local or systemic manifestations of the disease. benefits can be expected in patients with rash duration shorter than 72 hours. the use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles. 5. treatment of herpes simplex encephalitis.

Sodium Chloride and Glucose Intravenous Infusion Kenya - English - Pharmacy and Poisons Board

sodium chloride and glucose intravenous infusion

aculife healthcare pvt ltd commerce house-v, besides vodafone house, prahlad - sodium chloride and glucose intravenous infusion… - infusion - each 100 ml contains sodium chloride bp 0.9 gm… - mineral supplements: sodium

0.18 % w/v Sodium Chloride and 4 % w/v Glucose Intravenous Infusion BP, Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

0.18 % w/v sodium chloride and 4 % w/v glucose intravenous infusion bp, solution for infusion

b. braun medical limited - glucose; sodium chloride - solution for infusion - 0.18 and 4 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Glucose Intravenous Infusion BP 10% w/v, solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

glucose intravenous infusion bp 10% w/v, solution for infusion

b. braun medical limited - anhydrous glucose - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates